Stock MRYp MIRA IV ACQUISITION CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Mira IV Acquisition Corp Toronto S.E.

Equities

MRYp

CA60456Q1054

End-of-day quote Toronto S.E.
Other stock markets
- - Intraday chart for Mira IV Acquisition Corp
05-15 Transcript : Profound Medical Corp. - Shareholder/Analyst Call
05-14 Sector Update: Health Care Stocks Steady Premarket Tuesday MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Profound Medical : MATERIAL CHANGE REPORT Form 6 K
PU
PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS
AQ
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
AQ
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
AQ
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
AQ
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
AQ
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
AQ
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
AQ
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
AQ
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
AQ
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
AQ
Profound Medical Announces Non-Brokered Private Placement
AQ
Rising Nanocap Stars of Medical Technology (TBRIF, PROF, VPTDF, ATBPF)
AQ
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
AQ
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
AQ
Profound Medical Announces Proposed Public Offering of Common Shares
AQ
Profound Medical to Participate in the Stifel 2023 Healthcare Conference
AQ
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
AQ
Profound Medical Announces Third Quarter 2023 Financial Results
AQ
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 Conference Call to Follow
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRN Stock
  4. MRYp Stock
  5. News Mira IV Acquisition Corp
  6. Press Releases